News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlobeImmune, Inc. Offers IPO Details


9/6/2012 8:26:34 AM

GlobeImmune Inc. intends to offer 5 million shares at $11 to $13 in its planned initial public offering, it indicated in a securities filing Wednesday.

The Louisville-based pharmaceutical company is working on drugs to treat infectious diseases and cancers. GlobeImmune has said it plans to use proceeds from the IPO to fund clinical trials and for potential manufacturing.

GlobeImmune has filed to have its stock listed as “GBIM” on the Nasdaq Global Market.

The company has not announced a date for the offering.




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES